However, ROS-dependent alterations of TRPM4 activity in cancer cells have not yet been investigated and determining the contributions of TRPM4 to ROS-dependent alterations of Ca2+ signaling in cancer will be a challenge in the future. Here, TRPM4 is linked to cancer.